OnabotulinumtoxinA Disease Interactions
There are 3 disease interactions with onabotulinumtoxinA:
Botulinum toxin products (Includes onabotulinumtoxinA) ↔ dysphagia/respiratory disorders
Severe Potential Hazard, Moderate plausibility. Applies to: Dysphagia, Pulmonary Impairment, Myasthenia Gravis
Treatment with botulinum toxin products, including abobotulinumtoxinA, incobotulinumtoxinA, onabotulinumtoxinA, and others can result in swallowing or breathing difficulties. Deaths as a complication of severe dysphagia have been reported after treatment with botulinum toxin. Care should be exercised with using these products in patients with pre- existing swallowing or respiratory disorders as they may be more susceptible to these complications. Patients treated with botulinum toxin may require immediate medical attention should they develop problems with swallowing, speech or respiratory disorders.
Botulinum toxin products (Includes onabotulinumtoxinA) ↔ infection
Severe Potential Hazard, Moderate plausibility. Applies to: Infection - Bacterial/Fungal/Protozoal/Viral
Botulinum toxin products, including abobotulinumtoxinA, incobotulinumtoxinA, onabotulinumtoxinA, and others should not be used in the presence of infection at the proposed injection site(s) as it could lead to severe local or disseminated infection(s).
OnabotulinumtoxinA (Includes onabotulinumtoxinA) ↔ UTI
Severe Potential Hazard, Moderate plausibility. Applies to: Urinary Tract Infection, Urinary Retention
Botox (brand of onabotulinumtoxinA), a botulinum toxin product for the treatment of overactive bladder or detrusor overactivity associated with a neurologic condition should not be used in patients who have a urinary tract infection, in patients with urinary retention and in patients with post-void residual urine volume >200 mL, who are not routinely performing clean intermittent self-catheterization.
OnabotulinumtoxinA drug interactions
There are 380 drug interactions with onabotulinumtoxinA
More about onabotulinumtoxinA
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- En Español
- 304 Reviews
- Drug class: skeletal muscle relaxants
- FDA Alerts (1)
Related treatment guides
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.